GSK Consumer Healthcare tumbles on profit booking

GlaxoSmithkline Consumer Healthcare fell 4.86% to Rs 4,846.50 at 10:43 IST on BSE on profit booking after the stock jumped 30.60% in the preceding seven trading sessions to Rs 5093.95 on 17 May 2013 from a recent low of Rs 3900.30 on 9 May 2013.

Meanwhile, the BSE Sensex was up 139.75 points, or 0.69%, to 20,425.87.

On BSE, 3,201 shares were traded in the counter as against an average daily volume of 2,387 shares in the past one quarter.

The stock hit a high of Rs 5,100 and a low of Rs 4,824.30 so far during the day. The stock had hit a record high of Rs 5,248.90 on Friday, 17 May 2013. The stock had hit a 52-week low of Rs 2,179 on 18 July 2012.

The stock had outperformed the market over the past one month till 17 May 2013, soaring 29.65% compared with the Sensex's 8.30% rise. The scrip had also outperformed the market in past one quarter, surging 35.79% as against Sensex's 4.20% rise.

The large-cap company has an equity capital of Rs 42.06 crore. Face value per share is Rs 10.

GlaxoSmithkline Consumer Healthcare's net profit rose 18.5% to Rs 156.41 crore on 15.6% growth in net sales to Rs 939.86 crore in Q1 March 2013 over Q1 March 2012.

GlaxoSmithkline Consumer Healthcare is a leading player in the malted food drinks segment. Its major brands include Horlicks, Boost, Viva and Maltova.

Powered by Capital Market - Live News